Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sangeetha Murugapandian"'
Autor:
Iyad Mansour, MD, Sangeetha Murugapandian, MD, Bekir Tanriover, MD, MPH, MBA, FAST, Bijin Thajudeen, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 4, Pp 276-290 (2023)
Therapeutic monoclonal antibodies (MAbs) have been one of the fastest growing drug classes in the past 2 decades and are indicated in the treatment of cancer, autoimmune disorders, solid organ transplantation, and glomerular diseases. The Food and Dr
Externí odkaz:
https://doaj.org/article/f1679dbcac9142b5af3030e9307dd1a3
Autor:
Srilekha Sridhara, Ahmet B Gungor, Halil K Erol, Mohanad Al-Obaidi, Tirdad T Zangeneh, Edward J Bedrick, Venkatesh K Ariyamuthu, Aneesha Shetty, Abd A Qannus, Katherine Mendoza, Sangeetha Murugapandian, Gaurav Gupta, Bekir Tanriover
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0279326 (2023)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants are expected to be resistant to Bebtelovimab (BEB) monoclonal antibody (MAb) and the real-world experience regarding its effectiveness is scarce. This retrospective coho
Externí odkaz:
https://doaj.org/article/d89e9bff540f43528cd07aa89dd50e80
Publikováno v:
Clinics and Practice, Vol 4, Iss 3 (2014)
Infective endocarditis is a potentially life threatening condition. It is associated with high mortality and morbidity resulting mostly due to cardiorespiratory failure. Extracorporeal membrane oxygenation is a modality of treatment used to support h
Externí odkaz:
https://doaj.org/article/9ccfb76952b148e3ad8c4de00e152978
Autor:
Sangeetha Murugapandian, Ahmet B. Gungor, Mohanad Al-Obaidi, Bijin Thajudeen, Ryan C Wong, Iyad Mansour
Publikováno v:
Archives of Clinical and Biomedical Research.
Autor:
Srilekha Sridhara, Ahmet B. Gungor, Halil K. Erol, Mohanad Al-Obaidi, Tirdad T. Zangeneh, Edward J. Bedrick, Venkatesh K. Ariyamuthu, Aneesha Shetty, Abd A. Qannus, Katherine Mendoza, Sangeetha Murugapandian, Gaurav Gupta, Bekir Tanriover
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants are expected to be resistant to Bebtelovimab (BEB) monoclonal antibody (MAb) and the real-world experience regarding its effectiveness is scarce. This retrospective coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4590f2159033d645da9cf619713bb99c
https://doi.org/10.1101/2022.12.06.22283183
https://doi.org/10.1101/2022.12.06.22283183
Autor:
Mohanad M Al-Obaidi, Ahmet B Gungor, Saman Nematollahi, Tirdad T Zangeneh, Edward J Bedrick, Katherine M Johnson, Nicole E Low-Adegbija, Ruhaniyah Alam, Pooja Rangan, C William Heise, Venkatesh K Ariyamuthu, Aneesha Shetty, Abd Assalam Qannus, Sangeetha Murugapandian, Mehmet M S Ayvaci, Prince Mohan Anand, Bekir Tanriover
Publikováno v:
Open forum infectious diseases. 9(7)
Summary Retrospective analysis of the post–propensity score (PS)–matched cohort of 8426 outpatients balanced in clinical and demographic covariates showed that treatment with casirivimab-imdevimab monoclonal antibody was effective against the SAR
Autor:
Mahima Zandu, Sangeetha Murugapandian, Shailendra Singh, Madhan Shanmugasundaram, Arka Chatterjee
Publikováno v:
JACC: Cardiovascular Interventions. 16:S104
Publikováno v:
Current cardiology reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 23(4)
The purpose of this review is to examine recent evidence supporting CV safety profile and improvement of CV outcomes of some of the newer classes of diabetic medications. Diabetes mellitus (DM) is associated with increased risk of cardiovascular dise
Autor:
Mohamed Reza Movahed, Timir K. Paul, Sangeetha Murugapandian, Kristina Skinner, Madhan Shanmugasundaram, Mehrtash Hashemzadeh, Sachin Kumar
Publikováno v:
JACC: Cardiovascular Interventions. 13:S2-S3
Advanced chronic kidney disease (ACKD) is common in patients with acute myocardial infarction (AMI) and is associated with poor long-term outcomes. Patients with ACKD are less likely to receive evidence based pharmacologic or interventional therapies